Molecular structure of Cevimeline Hydrochloride Salt, CAS Number: 107220-28-0
Cevimeline Hydrochloride Salt (CAS 107220-28-0)
Alternate Names:
(±)-cis-2-Methylspiro[1,3-oxathiolane-5,3′-quinuclidine]; AF-102B; SNI-2011; Evoxac
Application:
Cevimeline Hydrochloride Salt is a novel mAChR M1 and mAChR M3 agonist
CAS Number:
107220-28-0
Molecular Weight:
235.77
Molecular Formula:
C10H17NOS•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Cevimeline Hydrochloride Salt is a novel, sialagogue, muscarinic M1 and M3 receptor agonist.
Cevimeline Hydrochloride Salt (CAS 107220-28-0) References
- Cevimeline. | Weber, J. and Keating, GM. 2008. Drugs. 68: 1691-8. PMID: 18681491
- Surgical therapy for gallstone disease. | Wetter, LA. and Way, LW. 1991. Gastroenterol Clin North Am. 20: 157-69. PMID: 2022419
- Cevimeline-induced monophasic salivation from the mouse submandibular gland: decreased Na+ content in saliva results from specific and early activation of Na+/H+ exchange. | Kondo, Y., et al. 2011. J Pharmacol Exp Ther. 337: 267-74. PMID: 21239510
- Egg White Alginate as a Novel Scaffold Biomaterial for 3D Salivary Cell Culturing. | Pham, HM., et al. 2021. Biomimetics (Basel). 7: PMID: 35076454
Activator of:
mAChR M1, and mAChR M3.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cevimeline Hydrochloride Salt, 5 mg | sc-207420 | 5 mg | $330.00 |